http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-202092636-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-575
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-575
filingDate 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-202092636-A1
titleOfInvention METHOD FOR SYNTHESIS OF 2-HYDROXY-6 - ((2- (1-ISOPROPYL-1H-PYRAZOL-5-YL) PYRIDIN-3-YL) METHOXY) BENZALDEHYDE
abstract The invention discloses methods for the synthesis of 2-hydroxy-6 - ((2- (1-isopropyl-1H-pyrazol-5-yl) pyridin-3-yl) methoxy) benzaldehyde (also referred to herein as compound (I)) and intermediates compounds used in such methods. Compound (I) binds to hemoglobin and increases its affinity for oxygen and, accordingly, can be useful for the treatment of diseases such as sickle cell anemia.
priorityDate 2016-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408686670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71602803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Total number of triples: 20.